RS102895 is a selective small molecule antagonist of the CCR2 chemokine receptor with an IC50 of 360 nM, demonstrating no appreciable activity against CCR1. It is a valuable research tool for investigating CCR2-mediated pathways in vitro and has been utilized in studies exploring monocyte migration and inflammatory disease models in vivo.